Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in  vitro.

In conclusion, the combination of isothiourea derivatives and hyperbaric oxygenation appears to be a promising therapeutic approach for malignant glioma treatment. PMID: 30896865 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research